InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Alafi Christopher D, Director. Insider active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 5 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €629k. Activity tracked since 21 May 2021. The latest transaction was filed on 27 May 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
8,482 shares@ US$40.0144.3% of flowCommon StockSEC:0001209191-21-036624:0
8,482 shares@ US$40.0144.3% of flowCommon StockSEC:0001209191-21-036624
1,100 shares@ US$40.005.7% of flowCommon StockSEC:0001209191-21-035750:0
1,100 shares@ US$40.005.7% of flowCommon StockSEC:0001209191-21-035750
195 sharesCommon StockSEC:0001209191-16-088867:0
5 of 5 declarations
About Alafi Christopher D
Christopher D. Alafi is a Board Member at Intra-Cellular Therapies, Inc. In this role, he contributes to overseeing the company's activities and making strategic decisions. Alafi brings his expertise in corporate governance and product development, which is essential for guiding the organization's direction. His commitment to innovation and research is an asset to the board.
